Copyright © 2001 by the European Society of Cardiology.
Editorial
Screening for drug-induced (acquired) long QT syndrome: is it time to apply new methods?
Laboratory of Cardiovascular Phamacology, Institute of Cardiac Surgery, University of Rome La Sapienza Rome, Italy
References
- Lande G, Kyndt F, Baró I. Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype. Eur Heart J. 2001;22:410422
[Abstract/Free Full Text] - Lehmann MH, Timothy KW, Frankovitch D. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotipically characterized long QT syndrome. J Am Coll Cardiol. 1997;29:9399[Abstract]
- Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88:782784
[Free Full Text] - Roden DM, Anderson ME. The pause that refreshes, or does it? Mechanisms in torsades de pointes (Editorial). Heart. 2000;84:235237
[Free Full Text] - Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998;98:23342351
[Free Full Text] - Carlsson L, Abrahamsson C, Drews L, Duker G. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation. 1992;85:14911500
[Abstract/Free Full Text] - Shimizu W, Antzelevitch C. Effects of a K+channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long QT syndrome. Circulation. 2000;102:706712
[Abstract/Free Full Text] - Crumb W, Cavero I. QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development. Pharm Sci Technol Today. 1999;2:270280[CrossRef][Medline]
- Criniti A, Picard S, Monti F. Cicletanine prevents the excitation-conduction blocks induced by terfenadine in ischemic myocardium. Eur J Pharmacol. 1999;382:197205[CrossRef][Web of Science][Medline]
- Pratt CM, Hertz RP, Ellis BE, Crowell SP, Louv W, Moyé L. Risk of developing life-threatening ventricular arrhythmias associated with terfenadine in comparison with overthe-counter antihistamines, ibuprofen and clemastine. Am J Cardiol. 1994;73:346352[CrossRef][Web of Science][Medline]
- Puddu, PE, Book Reviews: the long QT syndrome, by Schwartz PJ, Clinical approaches to tachyarrhythmias, Camm, AJ, Armonk, Futura Publishing, 1997, G Ital Cardiol, 1998, 28, 329, 30
- Dawodu AA, Monti F, Iwashiro K, Schiariti M, Chiavarelli R, Puddu PE. The shape of human atrial action potential accounts for different frequency-related changes in vitro. Int J Cardiol. 1996;54:237249[CrossRef][Web of Science][Medline]
- Rouet R, Picard S, Criniti A. Effects of bimakalim on human cardiac action potentials: comparison with guinea pig and nicorandil and use-dependent study. J Cardiovasc Pharmacol. 1999;33:255263[CrossRef][Web of Science][Medline]
- Puddu PE, Jouve R, Mariotti S. Evaluation of 10 QT prediction formulas in 881 middle-aged men from the Seven Countries Study: emphasis on the cubic root Fridericia's equation. J Electrocardiol. 1988;21:219229[CrossRef][Web of Science][Medline]
- Schulze-Bahr E, Haverkamp W, Hordt M. Do mutations in cardiac ion channel genes predispose to drug-induced (acquired) long-QT syndrome? (Abstr). Circulation. 1997;96:I211
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||